We know that heart disease is the leading cause of deaths in the USA, and Coronary Artery Disease (CAD) is the most usual type of heart disease. Regrettably, one half of all acute heart patients don't show conventional warning signs of cardiovascular illness. New tests present a more comprehensive appraisal of an person's risk factors. For cholesterol, this means examining more than just HDL, good cholesterol, and LDL, bad cholesterol, levels. We presently know that inside both LDL and HDL, there live particles that differ in their characteristics and consequently in their risk factors in LDL and protective factors in HDL for CAD.

Cholesterol is a fat-like matter detected in all body cells. LDL, a low-density conjugated protein having a lipid component found in the blood, is known as a bad carrier of cholesterol because high levels of LDL may bring on the development of heart disease. It is now achievable to assess LDL size and assign to a category as small LDL trait or large LDL trait. It is the small, dense LDL particles that elevate CAD danger. That is on account of the small LDL particles slide among the cells of the artery lining and are inclined to adhere to artery walls. When the particles stick to artery walls, it brings about the establishment of plaque. This is the procedure called atherosclerosis, placing you at bigger risk of a heart attack.

High-levels of HDL in the blood are thought to reduce the risk of heart disease. HDL is a high-density conjugated protein having a lipid component, and is believed a good provider of cholesterol. That is because HDL particles transport cholesterol from the cells out of the arterial wall, by way of the circulation, back to the liver where it can be cast from the body. This process, which suppresses atherosclerosis, is called reverse cholesterol transport. HDL 2B is the most vigorous of all the HDL particles in such transport. The higher HDL 2B you possess, the more effective the arterial cleansing process is. Less levels of HDL 2B raise cardiovascular risk. With testing, it is now likely to single out and determine the level of heart protective HDL 2B in the blood.

This particular approach can point to treatment that shows contrast from traditional therapy. It lets your doctor make a program for you that is more effective in lessening, stopping, or turning back the advancement of Coronary Artery Disease.